BEZ235 significantly inhibits cell proliferation in nasopharyngeal carcinoma both in vitro and in vivo by blocking the PI3K/AKT/mTOR pathway [17, 19]. This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.